UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14a
(RULE 14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
|
Filed by the Registrant ☒
|
|
|
Filed by a Party other than the Registrant ☐
|
|
|
Check the appropriate box:
|
|
|
☐
|
Preliminary proxy statement
|
|
☐
|
Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
☐
|
Definitive Proxy Statement
|
|
☒
|
Definitive Additional Materials
|
|
☐
|
Soliciting Material Pursuant to Sec.240.14a-12
|
|
CATALYST BIOSCIENCES, INC.
|
|
|
(Name of Registrant as Specified in its Charter)
|
|
|
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
|
|
|
Payment of Filing Fee (Check the appropriate box):
|
|
|
☒
|
No fee required.
|
|
☐
|
Fee paid previously with preliminary materials.
|
|
☐
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
|
Beginning on July 29, 2022, the following investor presentation may be provided to stockholders of Catalyst Biosciences, Inc. and to proxy advisory firms.
